Unilever
UL · LONDON
About UL
- Employees
- 96,092
- Headquarters
- London
- Listed
- Aug 11, 1939
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Website
- unilever.com
UL key statistics
- Market cap
- 107.19B
- Price-earnings ratio
- 0.00
- Dividend yield
- 3.32%
- Average volume
- 3.47M
- Volume
- 3.25M
- Open price
- $66.90
- High today
- $67.17
- Low today
- $65.91
- 52 Week high
- $80.32
- 52 Week low
- $54.75
Unilever (UL) at a glance
Unilever (UL) last traded at $66.23, with a market cap of 107.19B, a price-to-earnings ratio of 0.00 and a dividend yield of 3.32%.
Today the stock has traded between $65.91 and $67.17. The current price is 0.5% above the day's low and 1.4% below its high.
Volume so far is 3.25M shares, in line with the average of 3.47M shares a day.
Over the past year Unilever has ranged from $54.75 to $80.32, and now sits 45% of the way up that range.
Unilever met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q4 FY10 it reported $0.3412 per share against an estimate of $0.3339.
The average analyst price target is $72.00, 8.7% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $53.98
- Now
- $66.23
- High
- $84.17
UL earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 5.9% on average.
- Q4 FY08: reported $0.3789 per share against an estimate of $0.3109
- Q1 FY09: reported $0.3013 per share against an estimate of $0.3475
- Q2 FY09: reported $0.374 per share against an estimate of $0.3728
- Q3 FY09: reported $0.4259 per share against an estimate of $0.4222
- Q4 FY09: reported $0.3216 per share against an estimate of $0.3465
- Q2 FY10: reported $0.4259 per share against an estimate of $0.445
- Q3 FY10: reported $0.50 per share against an estimate of $0.4808
- Q4 FY10: reported $0.3412 per share against an estimate of $0.3339
UL news
- Press releaseBusiness Wire
'Unilever Seeks Buyers for Iconic British Mustard Brand Colman’s' - Bloomberg
Unilever Signs Partnership Growth Charter With Galaxy Surfactants Over Development Of Surfactant Technologies
- Erica Kollmann
Wildfire Smoke Spurs Fresh Demand for Masks, Putting 3M, Other Stocks In Focus
- Akanksha Bakshi
What's Going On With Accenture Stock Tuesday?
- Piero Cingari
The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels
- Bamboo Works
China's Shrinking 'Chicken King' Reportedly Eyeing Hong Kong IPO
Unilever To Invest Over $300M In AI-Powered Global Innovation Center In Connecticut To Accelerate Beauty, Personal Care And Wellbeing Product Innovation By 2029
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.